Sanofi Winthrop Industrie
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference a096ed8003
Drug names20First applicant · distinct drug namesAcceptance records163First applicant · distinct acceptance numbersUnder-review numbers30First applicant · current under-review listCo-applicant records75Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
163 acceptance records as first applicant, grouped into 20 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 6 records · Latest accepted 2026/11/02
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600306 | Supplement | 2026/11/02 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYSB2600132 | Supplement | 2026/05/27 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYSB2500260 | Supplement | 2025/11/05 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYSB2400174 | Supplement | 2024/08/09 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYSB2400100 | Supplement | 2024/05/06 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYSB2300196 | Supplement | 2023/11/11 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
No verified English name 4 records · Latest accepted 2026/10/26
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600298 | Supplement | 2026/10/26 | Sanofi Winthrop Industrie; Sanofi S.r.l. | CDE ↗ |
| JYSB2500080 | Supplement | 2025/03/26 | Sanofi Winthrop Industrie; Sanofi S.r.l. | CDE ↗ |
| JYSB2300125 | Supplement | 2023/07/19 | Sanofi Winthrop Industrie; Sanofi S.r.l. | CDE ↗ |
| JYSB2300124 | Supplement | 2023/07/19 | Sanofi Winthrop Industrie; Sanofi S.r.l. | CDE ↗ |
Irbesartan Tablets 14 records · Latest accepted 2026/10/12
Supplement · 10Import re-registration · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600549 | Supplement | 2026/10/12 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2600548 | Supplement | 2026/10/12 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHZ2600064 | Import re-registration | 2026/03/25 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHZ2600063 | Import re-registration | 2026/03/25 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHZ2600062 | Import re-registration | 2026/03/25 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHZ2600061 | Import re-registration | 2026/03/25 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2600065 | Supplement | 2026/01/27 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2600064 | Supplement | 2026/01/27 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300648 | Supplement | 2023/11/11 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300647 | Supplement | 2023/11/11 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300547 | Supplement | 2023/09/20 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300546 | Supplement | 2023/09/20 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300545 | Supplement | 2023/09/20 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300544 | Supplement | 2023/09/20 | Sanofi Winthrop Industrie | CDE ↗ |
No verified English name 42 records · Latest accepted 2026/09/22
Supplement · 20Not stated by source · 6Import · 12Import re-registration · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600265 | Supplement | 2026/09/22 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2600264 | Supplement | 2026/09/22 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2600263 | Supplement | 2026/09/22 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2600262 | Supplement | 2026/09/22 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2600139 | Supplement | 2026/06/04 | Sanofi Winthrop Industrie; Genzyme Ireland Limited | CDE ↗ |
| JYSB2600138 | Supplement | 2026/06/04 | Sanofi Winthrop Industrie; Genzyme Ireland Limited | CDE ↗ |
| JTS2600100 | Not stated by source | 2026/06/04 | Sanofi Winthrop Industrie; Shanghai Hong Cheng Pharma Co., Ltd. romanized | CDE ↗ |
| JTS2600099 | Not stated by source | 2026/06/04 | Sanofi Winthrop Industrie; Shanghai Hong Cheng Pharma Co., Ltd. romanized | CDE ↗ |
| JYSB2600070 | Supplement | 2026/04/01 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2600069 | Supplement | 2026/04/01 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2600068 | Supplement | 2026/04/01 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2600067 | Supplement | 2026/04/01 | Sanofi Winthrop Industrie | CDE ↗ |
| JTS2500123 | Not stated by source | 2025/11/04 | Sanofi Winthrop Industrie; Shanghai Hong Cheng Pharma Co., Ltd. romanized | CDE ↗ |
| JTS2500122 | Not stated by source | 2025/11/04 | Sanofi Winthrop Industrie; Shanghai Hong Cheng Pharma Co., Ltd. romanized | CDE ↗ |
| JTS2500121 | Not stated by source | 2025/11/04 | Sanofi Winthrop Industrie; Shanghai Hong Cheng Pharma Co., Ltd. romanized | CDE ↗ |
| JXSL2500201 | Import | 2025/10/16 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JTS2500095 | Not stated by source | 2025/10/14 | Sanofi Winthrop Industrie; Shanghai Hong Cheng Pharma Co., Ltd. romanized | CDE ↗ |
| JYSZ2500025 | Import re-registration | 2025/09/11 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYSZ2500024 | Import re-registration | 2025/09/11 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2500063 | Import | 2025/05/21 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2500062 | Import | 2025/05/21 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2500060 | Import | 2025/05/13 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2500059 | Import | 2025/05/13 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2500058 | Import | 2025/05/13 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2500057 | Import | 2025/05/13 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2500056 | Import | 2025/05/13 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2500055 | Import | 2025/05/13 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYSB2500079 | Supplement | 2025/03/25 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2500078 | Supplement | 2025/03/25 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2500077 | Supplement | 2025/03/25 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2500076 | Supplement | 2025/03/25 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2500069 | Supplement | 2025/03/19 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2500068 | Supplement | 2025/03/19 | Sanofi Winthrop Industrie | CDE ↗ |
| JXSS2500026 | Import | 2025/03/15 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2500025 | Import | 2025/03/15 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2400123 | Import | 2024/07/12 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYSZ2400041 | Import re-registration | 2024/07/06 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYSZ2400040 | Import re-registration | 2024/07/06 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYSB2400111 | Supplement | 2024/05/17 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2400110 | Supplement | 2024/05/17 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2400109 | Supplement | 2024/05/17 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2400108 | Supplement | 2024/05/17 | Sanofi Winthrop Industrie | CDE ↗ |
No verified English name 10 records · Latest accepted 2026/08/25
Supplement · 10
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600235 | Supplement | 2026/08/25 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2600214 | Supplement | 2026/07/23 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2600042 | Supplement | 2026/02/14 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2600023 | Supplement | 2026/01/26 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2500229 | Supplement | 2025/09/24 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2500132 | Supplement | 2025/06/14 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2500056 | Supplement | 2025/03/10 | Sanofi Winthrop Industrie; SANOFI PASTEUR | CDE ↗ |
| JYSB2500019 | Supplement | 2025/01/23 | Sanofi Winthrop Industrie | CDE ↗ |
| JYSB2500018 | Supplement | 2025/01/20 | Sanofi Winthrop Industrie; SANOFI PASTEUR | CDE ↗ |
| JYSB2500017 | Supplement | 2025/01/20 | Sanofi Winthrop Industrie; SANOFI PASTEUR | CDE ↗ |
Sevelamer Carbonate Tablets 4 records · Latest accepted 2026/08/19
Import re-registration · 2Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600199 | Import re-registration | 2026/08/19 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2600198 | Import re-registration | 2026/08/19 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2600364 | Supplement | 2026/07/01 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2600363 | Supplement | 2026/07/01 | Sanofi Winthrop Industrie | CDE ↗ |
No verified English name 18 records · Latest accepted 2026/08/07
Import · 2Supplement · 16
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2600072 | Import | 2026/08/07 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2600071 | Import | 2026/08/07 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYSB2600188 | Supplement | 2026/07/06 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2600187 | Supplement | 2026/07/06 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2500300 | Supplement | 2025/12/19 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2500299 | Supplement | 2025/12/19 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2500223 | Supplement | 2025/09/18 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2500222 | Supplement | 2025/09/18 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2500095 | Supplement | 2025/04/03 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC; Genzyme Corporation; Catalent Anagni S.r.l | CDE ↗ |
| JYSB2500094 | Supplement | 2025/04/03 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC; Genzyme Corporation; Catalent Anagni S.r.l | CDE ↗ |
| JYSB2500063 | Supplement | 2025/03/12 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2500062 | Supplement | 2025/03/12 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2400198 | Supplement | 2024/08/31 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2400197 | Supplement | 2024/08/31 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2400145 | Supplement | 2024/07/06 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2400144 | Supplement | 2024/07/06 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2400043 | Supplement | 2024/03/02 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2400042 | Supplement | 2024/03/02 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
Clopidogrel Hydrogen Sulphate Tablets 14 records · Latest accepted 2026/05/12
Import re-registration · 5Supplement · 9
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600117 | Import re-registration | 2026/05/12 | Sanofi Winthrop Industrie; Sanofi（China）Investment Co. Ltd. | CDE ↗ |
| JYHZ2600116 | Import re-registration | 2026/05/12 | Sanofi Winthrop Industrie; Sanofi（China）Investment Co. Ltd. | CDE ↗ |
| JYHB2500413 | Supplement | 2025/08/08 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2500412 | Supplement | 2025/08/08 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHZ2400233 | Import re-registration | 2024/08/24 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2400232 | Import re-registration | 2024/08/24 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2400231 | Import re-registration | 2024/08/24 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2300633 | Supplement | 2023/11/04 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300632 | Supplement | 2023/11/04 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300416 | Supplement | 2023/07/27 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300415 | Supplement | 2023/07/27 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300414 | Supplement | 2023/07/27 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300413 | Supplement | 2023/07/27 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300412 | Supplement | 2023/07/27 | Sanofi Winthrop Industrie | CDE ↗ |
No verified English name 11 records · Latest accepted 2026/01/27
Supplement · 11
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600063 | Supplement | 2026/01/27 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2500481 | Supplement | 2025/09/11 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2500480 | Supplement | 2025/09/11 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2400385 | Supplement | 2024/07/24 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2400384 | Supplement | 2024/07/24 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300640 | Supplement | 2023/11/08 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300639 | Supplement | 2023/11/08 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300638 | Supplement | 2023/11/08 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300637 | Supplement | 2023/11/08 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300381 | Supplement | 2023/07/08 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2300380 | Supplement | 2023/07/08 | Sanofi Winthrop Industrie | CDE ↗ |
No verified English name 6 records · Latest accepted 2026/01/14
Supplement · 2Import · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600011 | Supplement | 2026/01/14 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYSB2600010 | Supplement | 2026/01/14 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JXSS2400044 | Import | 2024/05/22 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JXSS2400043 | Import | 2024/05/22 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JXSS2300091 | Import | 2023/12/12 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2300090 | Import | 2023/12/12 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/09/16
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2500179 | Import | 2025/09/16 | Sanofi Winthrop Industrie; Shenzhen Sanofi Pasteur Biological Products Co. Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/08/12
Import · 2
No verified English name 2 records · Latest accepted 2025/02/27
Supplement · 2
No verified English name 1 records · Latest accepted 2025/02/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2500067 | Supplement | 2025/02/18 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE | CDE ↗ |
Amiodarone Hydrochloride Tablets 5 records · Latest accepted 2024/11/12
Import re-registration · 2Supplement · 2Not stated by source · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2400299 | Import re-registration | 2024/11/12 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHZ2400298 | Import re-registration | 2024/11/12 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2400158 | Supplement | 2024/04/11 | Sanofi Winthrop Industrie | CDE ↗ |
| JYHB2400157 | Supplement | 2024/04/11 | Sanofi Winthrop Industrie | CDE ↗ |
| JTH2200018 | Not stated by source | 2022/01/30 | Sanofi Winthrop Industrie; Sanofi-Aventis France; Sai Nuo Fei (Hangzhou) Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Docetaxel Injection 2 records · Latest accepted 2024/10/24
Supplement · 2
Amiodarone Hydrochloride Injection 5 records · Latest accepted 2024/07/18
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2400377 | Supplement | 2024/07/18 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE | CDE ↗ |
| JYHB2400023 | Supplement | 2024/01/19 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE | CDE ↗ |
| JYHB2400022 | Supplement | 2024/01/19 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE | CDE ↗ |
| JYHB2300335 | Supplement | 2023/06/13 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE; SANOFI S.r.l. | CDE ↗ |
| JYHB2300334 | Supplement | 2023/06/13 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE; SANOFI S.r.l. | CDE ↗ |
No verified English name 8 records · Latest accepted 2024/05/31
Supplement · 6Import re-registration · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2400114 | Supplement | 2024/05/31 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE | CDE ↗ |
| JYSB2400113 | Supplement | 2024/05/29 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE; Genzyme Ireland Ltd. | CDE ↗ |
| JYSZ2400006 | Import re-registration | 2024/01/11 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE; Sanofi（China）Investment Co. Ltd. | CDE ↗ |
| JYSZ2400005 | Import re-registration | 2024/01/11 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE; Sanofi（China）Investment Co. Ltd. | CDE ↗ |
| JYSB2300224 | Supplement | 2023/12/26 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE | CDE ↗ |
| JYSB2300223 | Supplement | 2023/12/26 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE | CDE ↗ |
| JYSB2300133 | Supplement | 2023/08/12 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE | CDE ↗ |
| JYSB2300132 | Supplement | 2023/08/12 | Sanofi Winthrop Industrie; SANOFI WINTHROP INDUSTRIE | CDE ↗ |
Amisulpride Tablets 2 records · Latest accepted 2024/02/02
Supplement · 2
No verified English name 6 records · Latest accepted 2023/08/25
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2300472 | Supplement | 2023/08/25 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYHB2300471 | Supplement | 2023/08/25 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYHB2300470 | Supplement | 2023/08/25 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYHB2300469 | Supplement | 2023/08/25 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYHB2300468 | Supplement | 2023/08/25 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| JYHB2300467 | Supplement | 2023/08/25 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
Changes in the last 90 days
11 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 11 applications
- 2026/11/02Accepted
No verified English name
JYSB2600306
Fact date: 2026/11/02 · Site observation date: 2026/11/03
View source ↗ - 2026/10/26Accepted
No verified English name
JYSB2600298
Fact date: 2026/10/26 · Site observation date: 2026/10/27
View source ↗ - 2026/10/12Accepted
Irbesartan Tablets
JYHB2600549
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗ - 2026/10/12Accepted
Irbesartan Tablets
JYHB2600548
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗ - 2026/09/22Accepted
No verified English name
JYSB2600265
Fact date: 2026/09/22 · Site observation date: 2026/10/22
View source ↗ - 2026/09/22Accepted
No verified English name
JYSB2600264
Fact date: 2026/09/22 · Site observation date: 2026/10/22
View source ↗ - 2026/09/22Accepted
No verified English name
JYSB2600263
Fact date: 2026/09/22 · Site observation date: 2026/10/22
View source ↗ - 2026/09/22Accepted
No verified English name
JYSB2600262
Fact date: 2026/09/22 · Site observation date: 2026/10/22
View source ↗ - 2026/08/25Accepted
No verified English name
JYSB2600235
Fact date: 2026/08/25 · Site observation date: 2026/10/22
View source ↗ - 2026/08/19Accepted
Sevelamer Carbonate Tablets
JYHZ2600199
Fact date: 2026/08/19 · Site observation date: 2026/10/22
View source ↗ - 2026/08/19Accepted
Sevelamer Carbonate Tablets
JYHZ2600198
Fact date: 2026/08/19 · Site observation date: 2026/10/22
View source ↗
Under review
30 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JYSB2600306 | Supplement | 2026/11/02 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| No verified English name | JYSB2600298 | Supplement | 2026/10/26 | Sanofi Winthrop Industrie; Sanofi S.r.l. | CDE ↗ |
| Irbesartan Tablets | JYHB2600549 | Supplement | 2026/10/12 | Sanofi Winthrop Industrie | CDE ↗ |
| Irbesartan Tablets | JYHB2600548 | Supplement | 2026/10/12 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2600265 | Supplement | 2026/09/22 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2600264 | Supplement | 2026/09/22 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2600263 | Supplement | 2026/09/22 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2600262 | Supplement | 2026/09/22 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2600235 | Supplement | 2026/08/25 | Sanofi Winthrop Industrie | CDE ↗ |
| Sevelamer Carbonate Tablets | JYHZ2600199 | Import re-registration | 2026/08/19 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| Sevelamer Carbonate Tablets | JYHZ2600198 | Import re-registration | 2026/08/19 | Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JXSS2600072 | Import | 2026/08/07 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JXSS2600071 | Import | 2026/08/07 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JYSB2600214 | Supplement | 2026/07/23 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2600188 | Supplement | 2026/07/06 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| No verified English name | JYSB2600187 | Supplement | 2026/07/06 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| No verified English name | JYSB2600139 | Supplement | 2026/06/04 | Sanofi Winthrop Industrie; Genzyme Ireland Limited | CDE ↗ |
| No verified English name | JYSB2600138 | Supplement | 2026/06/04 | Sanofi Winthrop Industrie; Genzyme Ireland Limited | CDE ↗ |
| No verified English name | JYSB2600070 | Supplement | 2026/04/01 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2600069 | Supplement | 2026/04/01 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2600068 | Supplement | 2026/04/01 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2600067 | Supplement | 2026/04/01 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2600023 | Supplement | 2026/01/26 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2500300 | Supplement | 2025/12/19 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| No verified English name | JYSB2500299 | Supplement | 2025/12/19 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC | CDE ↗ |
| No verified English name | JYSB2500229 | Supplement | 2025/09/24 | Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JXSS2500108 | Import | 2025/08/12 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| No verified English name | JXSS2500107 | Import | 2025/08/01 | Sanofi Winthrop Industrie; Sanofi-Aventis Deutschland GmbH | CDE ↗ |
| No verified English name | JYSB2500095 | Supplement | 2025/04/03 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC; Genzyme Corporation; Catalent Anagni S.r.l | CDE ↗ |
| No verified English name | JYSB2500094 | Supplement | 2025/04/03 | Sanofi Winthrop Industrie; Patheon Manufacturing Services LLC; Genzyme Corporation; Catalent Anagni S.r.l | CDE ↗ |
Catalogue holder records
0 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
5 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No verified English name | Sanofi Winthrop Industrie | Y20200001412 | A | 2025/04/04 | CDE ↗ |
| No verified English name | Sanofi Winthrop Industrie | Y20209990029 | A | 2025/04/04 | CDE ↗ |
| No verified English name | Sanofi Winthrop Industrie | Y20190009068 | A | 2025/03/19 | CDE ↗ |
| No verified English name | Sanofi Winthrop Industrie | Y20170002333 | A | 2025/12/07 | CDE ↗ |
| No verified English name | Sanofi Winthrop Industrie | Y20170002243 | A | 2024/09/24 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
75 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JTS2600135 | Not stated by source | 2026/07/30 | Sanofi S.r.l.; Sanofi Winthrop Industrie; Sai Nuo Fei (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| Clopidogrel Bisulfate and Aspirin Tablets | JYHB2600388 | Supplement | 2026/07/15 | sanofi-aventis Korea Co. Ltd.; Sanofi Winthrop Industrie | CDE ↗ |
| Clopidogrel Bisulfate and Aspirin Tablets | JYHZ2500249 | Import re-registration | 2025/11/06 | sanofi-aventis Korea Co. Ltd.; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| Mizolastine Sustained Release Tablets | JYHB2500559 | Supplement | 2025/10/24 | Desma Pharma; Sanofi Winthrop Industrie | CDE ↗ |
| Mizolastine Sustained Release Tablets | JYHB2500558 | Supplement | 2025/10/24 | Desma Pharma; Sanofi Winthrop Industrie | CDE ↗ |
| Sevelamer Carbonate Tablets | JYHB2500519 | Supplement | 2025/10/14 | Sanofi B.V.; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2500110 | Supplement | 2025/04/28 | Sanofi B. V.; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2500109 | Supplement | 2025/04/28 | Sanofi B. V.; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JTS2500021 | Not stated by source | 2025/04/11 | Sanofi-Aventis Deutschland GmbH; Sanofi Winthrop Industrie; Sai Nuo Fei (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JYHB2500038 | Supplement | 2025/02/06 | Sanofi-Aventis Ireland Limited T/A SANOFI; Sanofi Ilac Sanayi ve Ticaret Anonim Sirketi; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSZ2400026 | Import re-registration | 2024/05/16 | Sanofi B.V.; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JYSZ2400025 | Import re-registration | 2024/05/16 | Sanofi B.V.; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JYSB2400103 | Supplement | 2024/05/11 | Sanofi B.V.; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2400102 | Supplement | 2024/05/11 | Sanofi B.V.; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JXHB2400071 | Supplement | 2024/04/11 | Sanofi-Aventis Recherche & Développement; Sanofi-aventis recherche & développement; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JXHB2400070 | Supplement | 2024/04/11 | Genzyme Corporation; Sanofi-aventis recherche & développement; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2400077 | Supplement | 2024/04/04 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2400076 | Supplement | 2024/04/04 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JXSS2400003 | Import | 2024/01/25 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JXSS2400002 | Import | 2024/01/25 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JXHB2400014 | Supplement | 2024/01/06 | Sanofi-Aventis Recherche & Développement; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JXHB2400013 | Supplement | 2024/01/06 | Sanofi-Aventis Recherche & Développement; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JTS2300050 | Not stated by source | 2023/09/22 | Sanofi-Aventis Deutschland GmbH; Sanofi Winthrop Industrie; Sai Nuo Fei (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2300049 | Not stated by source | 2023/09/22 | Sanofi-Aventis Deutschland GmbH; Sanofi Winthrop Industrie; Sai Nuo Fei (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300207 | Not stated by source | 2023/08/26 | Sanofi-Aventis Deutschland GmbH; Sanofi Winthrop Industrie; Sai Nuo Fei (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300206 | Not stated by source | 2023/08/26 | Sanofi-Aventis Deutschland GmbH; Sanofi Winthrop Industrie; Sai Nuo Fei (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300205 | Not stated by source | 2023/08/26 | Sanofi-Aventis Deutschland GmbH; Sanofi Winthrop Industrie; Sai Nuo Fei (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300204 | Not stated by source | 2023/08/26 | Sanofi-Aventis Deutschland GmbH; Sanofi Winthrop Industrie; Sai Nuo Fei (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300203 | Not stated by source | 2023/08/26 | Sanofi-Aventis Deutschland GmbH; Sanofi Winthrop Industrie; Sai Nuo Fei (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JYSB2300135 | Supplement | 2023/08/15 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2300134 | Supplement | 2023/08/15 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JXHB2300105 | Supplement | 2023/06/19 | Genzyme Corporation; Sanofi-aventis recherche & développement; Sanofi Winthrop Industrie | CDE ↗ |
| Sevelamer Carbonate Tablets | JYHB2300199 | Supplement | 2023/03/28 | Genzyme Europe B.V.; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JXSS2300021 | Import | 2023/03/07 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| Clopidogrel Hydrogen Sulphate Tablets | JYHB2300127 | Supplement | 2023/02/16 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| Clopidogrel Hydrogen Sulphate Tablets | JYHB2300126 | Supplement | 2023/02/16 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JXSS2300010 | Import | 2023/01/12 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JXSS2300009 | Import | 2023/01/12 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JXSS2300008 | Import | 2023/01/12 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JXSS2300007 | Import | 2023/01/12 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JYSB2200208 | Supplement | 2022/10/22 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2200207 | Supplement | 2022/10/22 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| Alfuzosin Hydrochloride Prolonged Release Tablets | JYHZ2200282 | Import re-registration | 2022/10/13 | Sanofi-Aventis France; Sanofi Winthrop Industrie; Sanofi （China）Investment Co. Ltd. | CDE ↗ |
| Alfuzosin Hydrochloride Prolonged Release Tablets | JYHZ2200281 | Import re-registration | 2022/10/13 | Sanofi-Aventis France; Sanofi Winthrop Industrie; Sanofi （China）Investment Co. Ltd. | CDE ↗ |
| No verified English name | JYSB2200175 | Supplement | 2022/09/09 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2200174 | Supplement | 2022/09/09 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYHZ2200223 | Import re-registration | 2022/08/17 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JYHZ2200222 | Import re-registration | 2022/08/17 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JYHZ2200221 | Import re-registration | 2022/08/17 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JYHZ2200220 | Import re-registration | 2022/08/17 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JYSB2200081 | Supplement | 2022/05/07 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2200080 | Supplement | 2022/05/07 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| Mizolastine Sustained Release Tablets | JYHZ2200002 | Import re-registration | 2022/01/10 | Therabel Healthcare Limited; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| Mizolastine Sustained Release Tablets | JYHZ2200001 | Import re-registration | 2022/01/10 | Therabel Healthcare Limited; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| Clopidogrel Hydrogen Sulphate Tablets | JYHZ2100735 | Import re-registration | 2021/12/16 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi（China）Investment Co. Ltd. | CDE ↗ |
| Clopidogrel Hydrogen Sulphate Tablets | JYHZ2100734 | Import re-registration | 2021/12/16 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi（China）Investment Co. Ltd. | CDE ↗ |
| Irbesartan Tablets | JYHZ2100700 | Import re-registration | 2021/11/15 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi（China）Investment Co. Ltd. | CDE ↗ |
| Irbesartan Tablets | JYHZ2100699 | Import re-registration | 2021/11/15 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi（China）Investment Co. Ltd. | CDE ↗ |
| Irbesartan Tablets | JYHZ2100698 | Import re-registration | 2021/11/15 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi（China）Investment Co. Ltd. | CDE ↗ |
| Irbesartan Tablets | JYHZ2100697 | Import re-registration | 2021/11/15 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi（China）Investment Co. Ltd. | CDE ↗ |
| Teriflunomide Tablets | JYHB2101512 | Supplement | 2021/11/09 | Sanofi-aventis U.S. LLC; Sanofi Winthrop Industrie | CDE ↗ |
| Teriflunomide Tablets | JYHB2101511 | Supplement | 2021/11/09 | Sanofi-aventis U.S. LLC; Sanofi Winthrop Industrie | CDE ↗ |
| Mizolastine Sustained Release Tablets | JYHB2101430 | Supplement | 2021/09/22 | Therabel Healthcare Limited; Sanofi Winthrop Industrie | CDE ↗ |
| Mizolastine Sustained Release Tablets | JYHB2101429 | Supplement | 2021/09/22 | Therabel Healthcare Limited; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYHB2101412 | Supplement | 2021/09/15 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYHB2101411 | Supplement | 2021/09/15 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| Irbesartan Tablets | JYHB2101303 | Supplement | 2021/08/10 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| Irbesartan Tablets | JYHB2101302 | Supplement | 2021/08/10 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JXHB2101053 | Supplement | 2021/08/09 | Genzyme Corporation; Sanofi-aventis recherche & développement; Sanofi Winthrop Industrie | CDE ↗ |
| Amiodarone Hydrochloride Tablets | JYHB2101215 | Supplement | 2021/06/30 | Sanofi-Aventis France; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JXSS2101006 | Import | 2021/05/10 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| No verified English name | JXSS2101005 | Import | 2021/05/10 | Sanofi-aventis groupe; Sanofi Winthrop Industrie; Sanofi (China) Investment Co. Ltd. | CDE ↗ |
| Clopidogrel Hydrogen Sulphate Tablets | JYHB2101043 | Supplement | 2021/04/14 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| Clopidogrel Hydrogen Sulphate Tablets | JYHB2101042 | Supplement | 2021/04/14 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
| No verified English name | JYSB2000683 | Supplement | 2021/01/01 | Sanofi-aventis groupe; Sanofi Winthrop Industrie | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.